Literature DB >> 18166738

Corticosteroids and erythropoeitin-receptor agonists.

Craig S McLachlan.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18166738      PMCID: PMC2151124          DOI: 10.1503/cmaj.1070144

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  JNK and p38 are activated by erythropoietin (EPO) but are not induced in apoptosis following EPO withdrawal in EPO-dependent HCD57 cells.

Authors:  S M Jacobs-Helber; J J Ryan; S T Sawyer
Journal:  Blood       Date:  2000-08-01       Impact factor: 22.113

2.  Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury.

Authors:  Alfredo Gorio; Laura Madaschi; Barbara Di Stefano; Stephana Carelli; Anna Maria Di Giulio; Silvia De Biasi; Thomas Coleman; Anthony Cerami; Michael Brines
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-31       Impact factor: 11.205

3.  Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials.

Authors:  Ryan Zarychanski; Alexis F Turgeon; Lauralyn McIntyre; Dean A Fergusson
Journal:  CMAJ       Date:  2007-09-05       Impact factor: 8.262

4.  Corticosteroids influence the mortality and morbidity of acute critical illness.

Authors:  Mohamed Y Rady; Daniel J Johnson; Bhavesh Patel; Joel Larson; Richard Helmers
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

5.  Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1.

Authors:  Sonya M Abraham; Toby Lawrence; Anna Kleiman; Paul Warden; Mino Medghalchi; Jan Tuckermann; Jeremy Saklatvala; Andrew R Clark
Journal:  J Exp Med       Date:  2006-07-31       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.